关注
Timir Tripathi
Timir Tripathi
Professor
在 nehu.ac.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
One year update on the COVID-19 pandemic: Where are we now?
SK Mishra, T Tripathi
Acta tropica 214, 105778, 2021
2392021
Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
P Kalita, AK Padhi, KYJ Zhang, T Tripathi
Microbial Pathogenesis 145, 104236, 2020
2162020
Current and novel therapeutic molecules and targets in Alzheimer's disease
A Kumar, CM Nisha, C Silakari, I Sharma, K Anusha, N Gupta, P Nair, ...
Journal of the Formosan Medical Association 115 (1), 3-10, 2016
1732016
Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase
CM Nisha, A Kumar, P Nair, N Gupta, C Silakari, T Tripathi, A Kumar
Advances in bioinformatics 2016 (1), 9258578, 2016
1452016
Aminoacyl-tRNA synthetases: Structure, function, and drug discovery
V Rajendran, P Kalita, H Shukla, A Kumar, T Tripathi
International journal of biological macromolecules 111, 400-414, 2018
1252018
Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy
S Verma, A Kumar, T Tripathi, A Kumar
Journal of Pharmacy and Pharmacology 70 (8), 985-993, 2018
1172018
An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli
G Chhetri, P Kalita, T Tripathi
MethodsX 2, 385-391, 2015
1152015
Molecular dynamics simulation of protein and protein–ligand complexes
R Shukla, T Tripathi
Computer-aided drug design, 133-161, 2020
882020
High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance
AK Padhi, R Shukla, P Saudagar, T Tripathi
Iscience 24 (1), 2021
76*2021
Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
AK Padhi, A Seal, JM Khan, M Ahamed, T Tripathi
European journal of pharmacology 894, 173836, 2021
74*2021
Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase
R Shukla, H Shukla, A Sonkar, T Pandey, T Tripathi
Journal of Biomolecular Structure and Dynamics 36 (8), 2045-2057, 2018
722018
Frontiers in protein structure, function, and dynamics
DB Singh, T Tripathi
Springer 10, 978-981, 2020
712020
Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach
P Kalita, DL Lyngdoh, AK Padhi, H Shukla, T Tripathi
International journal of biological macromolecules 138, 224-233, 2019
692019
Can SARS-CoV-2 accumulate mutations in the S-protein to increase pathogenicity?
AK Padhi, T Tripathi
ACS Pharmacology & Translational Science 3 (5), 1023-1026, 2020
632020
Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility
H Shukla, R Shukla, A Sonkar, T Pandey, T Tripathi
Scientific reports 7 (1), 1058, 2017
632017
Accelerating COVID-19 research using molecular dynamics simulation
AK Padhi, SL Rath, T Tripathi
The Journal of Physical Chemistry B 125 (32), 9078-9091, 2021
602021
Autophagy modulation as a treatment of amyloid diseases
Z Mputhia, E Hone, T Tripathi, T Sargeant, R Martins, P Bharadwaj
Molecules 24 (18), 3372, 2019
582019
Calculation of thermodynamic parameters of protein unfolding using far-ultraviolet circular dichroism
T Tripathi
J Proteins Proteomics 4 (2), 85-91, 2013
562013
Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies
R Shukla, H Shukla, P Kalita, A Sonkar, T Pandey, DB Singh, A Kumar, ...
Journal of Biomolecular Structure and Dynamics 36 (8), 2147-2162, 2018
522018
Advances in protein molecular and structural biology methods
T Tripathi, VK Dubey
Academic Press, 2022
492022
系统目前无法执行此操作,请稍后再试。
文章 1–20